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In part I of this thesis we examined the quality and safety of care via literature study (chapter 1), 
conducted a cross-sectional survey accompanied with interviews at emergency departments 
(chapter 2) and we analyzed the trend of the Customer Quality index of Dutch hospitals in the 
period 2006 – 2009 (chapter 3). Based on the findings in these chapters we conclude that there is 
substantial potential for improving quality of care. Chapter 1 shows that processes (care pathways) 
in health care in comparison with other industries are relative unreliable and that most hospitals 
are still in the early development (phase 0 to phase 1) of assuring quality and safety of care. This 
finding is confirmed in chapter 2, which shows that none of the 27 emergency departments that 
were sampled complied to minimum quality standards. A first step in improving the reliability of 
high risk processes may be complying to the quality requirement framework in chapter 2, but actual 
measurement of outcomes and process compliance and steering by professionals and management 
to improve these outcomes, will be essential to substantially improve the quality of care. In chapter 
3 we show that the introduction of transparency and competition as part of the health reform in 
2006 seems to have improved patient experiences in Dutch hospitals. If one combines the findings 
of chapter 1, 2 and 3, one may conclude that focusing on the measurement of outcomes of care 
and publishing these outcomes in concordance with the development of quality requirement 
frameworks may be a fruitful route to further improve the quality of care in the Dutch health care 
system.
In part II of this thesis we analyzed the costs, efficiency and accessibility of the hospital system 
by examining all (day)clinical Diagnosis Treatment Combinations (DTCs) in the period 2006-2009 
(chapter 4). In chapter 5 we provide the results of a regional study around the city of Eindhoven 
were GPs worked with report cards. Based on the findings in chapter 4 we conclude that the 
introduction of standardized ‘products’ (DTCs), transparency of quality and negotiable prices and 
volumes for DTCs have led to improvement of efficiency, lower prices and marginally improved 
accessibility of care on a product level. Nonetheless substantial volume increases within the so 
called ‘B-segment’ outweigh the gains in efficiency of care and therefore total costs in the period 
2006 to 2009 rose at an unsustainable fast rate. In addition, we see that once DTCs enter the 
B-segment, efficiency gains - compared to previous years of these DTCs and other DTCs within 
the same year - decrease, probably due to a shift of focus for these DTCs by hospitals towards 
volume growth instead of realizing additional efficiency improvements for these DTCs. In chapter 
5 we show that the current level of transparency in the hospital market is too limited to result in 
substantial volumes of patients and/or GPs that choose for the ‘best’ hospital. For patients (and 
GPs) to act in the role of envisioned ‘change agent’, easily accessible, risk-adjusted outcomes of 
quality of care are needed.  
In part III of this thesis we described potential strategies to (further) improve value of care. In 
chapter 6 we measure the developments in costs and quality of care in the different health care 
sectors using the value-based competition theory. In chapter 7 we present a new method to 
make the trade-off between accessibility and quality of care for one specific diagnosis (breast 
cancer). In chapter 8 we use the methodology of chapter 7 to gauge how the hospital landscape 
in the Netherlands would look like if one would optimize the value of care. Based on the findings 
in chapter 6 we conclude that in the first years after the health reform it seems that primarily the 
principles of the value-based competition theory (outcome measurement, bundled payments, 
competition between providers - as described by Michael Porter) improved efficiency and quality 
of care (at a product level) rather than health plans that selectively purchase care products. The 
main finding of chapter 7 is that via concentration of breast cancer care in the Netherlands in 15 to 
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44 centers the quality of care can be improved and that this outweighs the lessened accessibility 
of care according to patient preferences. Therefore by concentrating breast cancer care in fewer 
centers the total value of breast cancer care can be optimized. In chapter 8 we gauge how the 
Dutch hospital landscape would look like if one would optimize the societal value of hospital 
care using the methodology of chapter 7. We come to the conclusion that there seems to be an 
mismatch between the current hospital landscape and patient preferences; the current hospital 
landscape for complex care may be too dispersed, while for basic care it may be too concentrated 
and care could be provided in non-hospital settings in the proximity of patients. 
We come to the conclusion that the current way of contracting hospitals via pay-for-performance 
systems is not a viable strategy to significantly improve value of care. Where value measurement 
once looked like a theoretical perceptive, the latest developments show that value measurement 
is feasible for the majority of care by using administrative data within the year 2012 already. In 
addition, for diagnosis where administrative data may not be the most valid source for value 
measurement clinical registries (such as the NICE for ICU care and the National Trauma Care registry 
for trauma care) can provide these insights, together with Patient Reported Outcome Measures 
(PROMs). To really improve value in health care, health plans should purchase integral health care 
products using three principles that are already routine in other parts of the economy: 1) define a 
meaningful health care product 2) measure the outcomes (costs and quality) of this product 3) pay 
for these outcomes rather than activities. By using this new way of contracting in combination with 
reducing redundant hospital capacity, it should be possible to make the next step in health care 
reform: realizing a cost growth that is in line with demographic trends and technological innovations 
while at the same time improving quality of care.
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